Status:
COMPLETED
Low Sirtuin-1 Levels Are Linked to Erythropoietin Resistance in Hemodialysis Patients.
Lead Sponsor:
Cuma Bulent Gul
Collaborating Sponsors:
Bursa Yuksek Ihtisas Training and Research Hospital
Conditions:
Chronic Kidney Disease
Hemodialysis
Eligibility:
All Genders
18+ years
Brief Summary
This study investigates the relationship between Sirtuin-1 (SIRT1) levels and erythropoietin resistance in hemodialysis patients. The study aims to determine whether low SIRT1 levels contribute to EPO...
Detailed Description
This study explores the association between Sirtuin-1 (SIRT1) levels and erythropoietin resistance in hemodialysis patients. Erythropoiesis-stimulating agents (ESAs) are commonly used to treat anemia ...
Eligibility Criteria
Inclusion
- Aged ≥18 years
- Receiving hemodialysis
- Availability of laboratory data to calculate ERI
Exclusion
- Autosomal polycystic kidney disease
- Malignancies
- Infectious diseases
- Chronic rheumatological disorders
- Vitamin B12 or folic acid deficiency
- CRP levels ≥ 5 mg/L
- PTH levels ≥ 300 pg/dL
- Inadequate hemodialysis (Kt/Vurea \< 1.2)
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2021
Estimated Enrollment :
391 Patients enrolled
Trial Details
Trial ID
NCT06877286
Start Date
August 1 2020
End Date
October 15 2021
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uludag University Medical School
Bursa, Turkey (Türkiye), 16059